Filed 1.7y ago· Sep 4, 2024
6 days to disclose
Kathy Manning
DHouseNorth Carolina-06
↑bought
Pfizer
PFE
$15K-$50K
−2.8% vs S&P 500
Trade dateAug 29, 2024
Pfizer, Inc.
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–46 of 46
Filed 1.8y ago· Aug 16, 2024
45 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
AbbVie
ABBV
$1K-$15K
+26.3% vs S&P 500
Trade dateJul 2, 2024
Filed 1.8y ago· Aug 16, 2024
45 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+55.6% vs S&P 500
Trade dateJul 2, 2024
Filed 1.8y ago· Aug 16, 2024
45 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+55.6% vs S&P 500
Trade dateJul 2, 2024
Filed 1.8y ago· Aug 16, 2024
45 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Amgen
AMGN
$1K-$15K
+2.6% vs S&P 500
Trade dateJul 2, 2024
Filed 1.8y ago· Aug 16, 2024
45 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Merck
MRK
$1K-$15K
−13.9% vs S&P 500
Trade dateJul 2, 2024
Stock
Filed 2.3y ago· Feb 6, 2024
5 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
AbbVie
ABBV
$500K-$1M
+23.4% vs S&P 500
Trade dateFeb 1, 2024
Filed 2.3y ago· Feb 6, 2024
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Merck
MRK
$15K-$50K
−11.3% vs S&P 500
Trade dateJan 23, 2024
Stock
Filed 2.3y ago· Feb 6, 2024
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Merck
MRK
$1K-$15K
−11.3% vs S&P 500
Trade dateJan 23, 2024
Stock
Filed 2.3y ago· Feb 6, 2024
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Amgen
AMGN
$1K-$15K
−0.4% vs S&P 500
Trade dateJan 23, 2024
Filed 2.3y ago· Feb 6, 2024
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Merck
MRK
$1K-$15K
−11.3% vs S&P 500
Trade dateJan 23, 2024
Stock
Filed 2.3y ago· Feb 6, 2024
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+6.1% vs S&P 500
Trade dateJan 23, 2024
Filed 2.4y ago· Jan 12, 2024
31 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Pfizer
PFE
$1K-$15K
+11.2% vs S&P 500
Trade dateDec 12, 2023
Filed 3.0y ago· May 19, 2023
21 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Amgen
AMGN
$1K-$15K
+25.4% vs S&P 500
Trade dateApr 28, 2023
Filed 3.0y ago· May 19, 2023
21 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
AbbVie
ABBV
$1K-$15K
+30.6% vs S&P 500
Trade dateApr 28, 2023
Filed 3.0y ago· May 19, 2023
21 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
AbbVie
ABBV
$1K-$15K
+11.2% vs S&P 500
Trade dateApr 28, 2023
Filed 3.0y ago· May 19, 2023
21 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
AbbVie
ABBV
$1K-$15K
+11.2% vs S&P 500
Trade dateApr 28, 2023
Filed 3.6y ago· Nov 10, 2022
29 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Amgen
AMGN
$1K-$15K
+21.8% vs S&P 500
Trade dateOct 12, 2022
Filed 3.6y ago· Nov 10, 2022
29 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Pfizer
PFE
$1K-$15K
−58.7% vs S&P 500
Trade dateOct 12, 2022
Filed 3.6y ago· Nov 10, 2022
29 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+20.3% vs S&P 500
Trade dateOct 12, 2022
Filed 3.6y ago· Oct 11, 2022
29 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Merck
MRK
$1K-$15K
+15.8% vs S&P 500
Trade dateSep 12, 2022
Stock
Filed 3.6y ago· Oct 11, 2022
29 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+26.6% vs S&P 500
Trade dateSep 12, 2022
Filed 3.6y ago· Oct 11, 2022
29 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Pfizer
PFE
$1K-$15K
+13.0% vs S&P 500
Trade dateSep 12, 2022
Filed 3.6y ago· Oct 11, 2022
29 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
AbbVie
ABBV
$1K-$15K
+13.0% vs S&P 500
Trade dateSep 12, 2022
Filed 3.7y ago· Sep 14, 2022
40 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Merck
MRK
$1K-$15K
+13.0% vs S&P 500
Trade dateAug 5, 2022
Stock
Filed 3.7y ago· Sep 14, 2022
42 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+12.4% vs S&P 500
Trade dateAug 3, 2022
Filed 3.7y ago· Sep 14, 2022
42 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Biogen
BIIB
$1K-$15K
+12.4% vs S&P 500
Trade dateAug 3, 2022
Filed 3.7y ago· Sep 14, 2022
42 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Amgen
AMGN
$1K-$15K
+12.4% vs S&P 500
Trade dateAug 3, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
AbbVie
ABBV
$1K-$15K
+29.3% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Pfizer
PFE
$1K-$15K
−61.4% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Amgen
AMGN
$1K-$15K
+17.6% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Amgen
AMGN
$1K-$15K
+12.5% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Amgen
AMGN
$1K-$15K
+17.6% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Amgen
AMGN
$1K-$15K
+12.5% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
AbbVie
ABBV
$15K-$50K
+12.5% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
AbbVie
ABBV
$1K-$15K
+29.3% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Eli Lilly
LLY
$1K-$15K
+208.4% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
26 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+15.7% vs S&P 500
Trade dateJul 15, 2022
Filed 3.8y ago· Aug 10, 2022
26 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Merck
MRK
$1K-$15K
+5.5% vs S&P 500
Trade dateJul 15, 2022
Stock
Filed 3.8y ago· Aug 10, 2022
26 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Pfizer
PFE
$1K-$15K
−63.3% vs S&P 500
Trade dateJul 15, 2022
Filed 3.8y ago· Aug 10, 2022
26 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Biogen
BIIB
$1K-$15K
−26.2% vs S&P 500
Trade dateJul 15, 2022
Filed 3.8y ago· Aug 10, 2022
26 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−41.8% vs S&P 500
Trade dateJul 15, 2022
Filed 4.3y ago· Feb 11, 2022
30 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Biogen
BIIB
$15K-$30K
−24.2% vs S&P 500
Trade dateJan 12, 2022
Filed 5.1y ago· May 6, 2021
6 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
AbbVie
ABBV
$1K-$15K
−7.1% vs S&P 500
Trade dateApr 30, 2021
Filed 5.1y ago· May 6, 2021
6 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$15K-$30K
−31.3% vs S&P 500
Trade dateApr 30, 2021
Filed 5.1y ago· May 6, 2021
6 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Amgen
AMGN
$1K-$15K
+27.3% vs S&P 500
Trade dateApr 30, 2021
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Sep 4, 2024 1.7y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Pfizer PFE Pfizer, Inc. | Aug 29, 2024 6 days to disclose | Bad buy·−$2.5K-7.6% −2.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 16, 2024 1.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | AbbVie ABBV | Jul 2, 2024 45 days to disclose | Good buy·+$2.3K+29.1% +26.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Jul 2, 2024 45 days to disclose | Good buy·+$4.7K+58.4% +55.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Jul 2, 2024 45 days to disclose | Good buy·+$4.7K+58.4% +55.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Amgen AMGN | Jul 2, 2024 45 days to disclose | Good buy·+$432+5.4% +2.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Merck MRK Stock | Jul 2, 2024 45 days to disclose | Bad buy·−$887-11.1% −13.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 6, 2024 2.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | AbbVie ABBV | Feb 1, 2024 5 days to disclose | Good buy·+$209.1K+27.9% +23.4% vs S&P 500 | $500K-$1M midpoint $750K |
Feb 6, 2024 2.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Merck MRK Stock | Jan 23, 2024 14 days to disclose | Bad buy·−$1.7K-5.2% −11.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 6, 2024 2.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Merck MRK Stock | Jan 23, 2024 14 days to disclose | Bad buy·−$419-5.2% −11.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 6, 2024 2.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Amgen AMGN | Jan 23, 2024 14 days to disclose | Good buy·+$456+5.7% −0.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 6, 2024 2.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Merck MRK Stock | Jan 23, 2024 14 days to disclose | Bad buy·−$419-5.2% −11.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 6, 2024 2.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Johnson & Johnson JNJ | Jan 23, 2024 14 days to disclose | Flat·+0.0% +6.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2024 2.4y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Pfizer PFE | Dec 12, 2023 31 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Amgen AMGN | Apr 28, 2023 21 days to disclose | Good buy·+$2.9K+36.6% +25.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | AbbVie ABBV | Apr 28, 2023 21 days to disclose | Good buy·+$3.3K+41.8% +30.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | AbbVie ABBV | Apr 28, 2023 21 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | AbbVie ABBV | Apr 28, 2023 21 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 10, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Amgen AMGN | Oct 12, 2022 29 days to disclose | Flat·+0.0% +21.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 10, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Pfizer PFE | Oct 12, 2022 29 days to disclose | Bad buy·−$3K-36.9% −58.7% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 10, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Oct 12, 2022 29 days to disclose | Good buy·+$3.4K+42.2% +20.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 11, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Merck MRK Stock | Sep 12, 2022 29 days to disclose | Good buy·+$2.3K+28.8% +15.8% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 11, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Sep 12, 2022 29 days to disclose | Good buy·+$3.2K+39.6% +26.6% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 11, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Pfizer PFE | Sep 12, 2022 29 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 11, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | AbbVie ABBV | Sep 12, 2022 29 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 14, 2022 3.7y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Merck MRK Stock | Aug 5, 2022 40 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 14, 2022 3.7y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Johnson & Johnson JNJ | Aug 3, 2022 42 days to disclose | Flat·+0.0% +12.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 14, 2022 3.7y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Biogen BIIB | Aug 3, 2022 42 days to disclose | Flat·+0.0% +12.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 14, 2022 3.7y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Amgen AMGN | Aug 3, 2022 42 days to disclose | Flat·+0.0% +12.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | AbbVie ABBV | Jul 27, 2022 14 days to disclose | Good buy·+$3.3K+41.8% +29.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Pfizer PFE | Jul 27, 2022 14 days to disclose | Bad buy·−$3.9K-48.9% −61.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Amgen AMGN | Jul 27, 2022 14 days to disclose | Good buy·+$2.4K+30.1% +17.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Amgen AMGN | Jul 27, 2022 14 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Amgen AMGN | Jul 27, 2022 14 days to disclose | Good buy·+$2.4K+30.1% +17.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Amgen AMGN | Jul 27, 2022 14 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | AbbVie ABBV | Jul 27, 2022 14 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | AbbVie ABBV | Jul 27, 2022 14 days to disclose | Good buy·+$3.3K+41.8% +29.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Eli Lilly LLY | Jul 27, 2022 14 days to disclose | Good buy·+$17.7K+220.9% +208.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Jul 15, 2022 26 days to disclose | Good buy·+$2.4K+29.8% +15.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Merck MRK Stock | Jul 15, 2022 26 days to disclose | Good buy·+$1.6K+19.6% +5.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Pfizer PFE | Jul 15, 2022 26 days to disclose | Bad buy·−$3.9K-49.3% −63.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Biogen BIIB | Jul 15, 2022 26 days to disclose | Bad buy·−$971-12.1% −26.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Bristol-Myers Squibb BMY | Jul 15, 2022 26 days to disclose | Bad buy·−$2.2K-27.7% −41.8% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2022 4.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Biogen BIIB | Jan 12, 2022 30 days to disclose | Bad buy·−$3.5K-15.4% −24.2% vs S&P 500 | $15K-$30K midpoint $22.5K |
May 6, 2021 5.1y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | AbbVie ABBV | Apr 30, 2021 6 days to disclose | Missed gain·−$6.3K-78.2% −7.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2021 5.1y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Apr 30, 2021 6 days to disclose | Good buy·+$9K+39.8% −31.3% vs S&P 500 | $15K-$30K midpoint $22.5K |
May 6, 2021 5.1y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Amgen AMGN | Apr 30, 2021 6 days to disclose | Missed gain·−$3.5K-43.8% +27.3% vs S&P 500 | $1K-$15K midpoint $8K |